Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2025 07:00 ET | Source: Transpire Bio

Transpire Bio Announces R&D and Manufacturing Expansion

Transpire Bio has signed an agreement to expand the footprint of its R&D and Manufacturing capabilities in Pembroke Pines, Florida
May 10, 2023 09:15 ET | Source: Kexing Biopharm

Led by Sci-tech Innovation, Expanding into Global Markets - Kexing Biopharm in International Exhibitions

Shenzhen, China, May 10, 2023 (GLOBE NEWSWIRE) -- As internationalization gradually becomes the mainstream trend of development for China's biopharmaceutical industry, enterprises have intensified...
October 20, 2022 14:20 ET | Source: Cingulate Inc.

Cingulate to Present at LD Micro Investor Conference

KANSAS CITY, Kan., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
August 04, 2022 09:00 ET | Source: Global Market Estimates

Global Biopharmaceutical Stability Testing Market Size

Brooklyn, New York, Aug. 04, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Biopharmaceutical Stability Testing Market is...
May 18, 2022 17:20 ET | Source: Cingulate Inc.

Cingulate to Present at H.C. Wainwright Global Investment Conference

KANSAS CITY, Kan., May 18, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery...
January 07, 2019 10:43 ET | Source: MaRS Innovation

Fibrocor, a MaRS Innovation portfolio company, announces deal with Galapagos

Toronto, ON, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Fibrocor Therapeutics, a privately held Canadian company, and Galapagos NV, a Belgo-Dutch pharmaceutical research company, have announced the formation...